Scientists seek to predict best outcomes for prostate surgery

NCT ID NCT07429994

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study aims to find out what factors help predict a successful outcome after a type of prostate surgery called HoLEP, which treats an enlarged prostate. Researchers will follow 604 men aged 40 and older who are scheduled for HoLEP. They will measure success based on symptom relief, no urinary incontinence, and no serious complications three months after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help surgeons identify which patients are most likely to have a smooth recovery and good results after HoLEP surgery.

What could go wrong

This is an observational study, not a treatment trial. It won't test a new drug or procedure, so it won't directly lead to a cure or new therapy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HOLEP are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia bladder neck obstruction Lower Urinary Tract Symptoms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Ondokuz Mayis University, Samsun

    Samsun, Turkey (Türkiye)

    Contact Phone: •••-•••-•••• Email: •••••@•••••